{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:49:20Z","timestamp":1775008160934,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A safe and effective vaccine is the ultimate key to mitigating the COVID-19 pandemic. Vaccine acceptance is influenced by various factors, including perceptions about the vaccine\u2019s safety and side effects. The side effects vary depending on the type of the vaccine, but they are mainly mild, local, temporary, and self-limiting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional study was carried out at Tanta University Hospitals, including 1246 healthcare workers who received either the first or the second dose of the COVID-19 vaccine, selected via a systematic random sampling technique using a self-administered structured validated questionnaire for data collection from November 2021 to January 2022. Qualitative data were presented as frequencies and percentages and analyzed using Chi-square and Fisher\u2019s exact tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of one or more side effects was 91.3%. Among participants, about two-thirds believed in vaccine safety and its necessity (65.4% and 63.6%, respectively). Significantly more participants (46.9%) were concerned about AstraZeneca thrombotic complications than other vaccine types. The top five side effects reported by participants were injection site pain (64.8%), sense of fatigue (57.1%), headache (49.9%), muscle pain (48.7%), and fever (46.5). Most of the side effects were significantly higher among participants vaccinated with AstraZeneca. Side effects impacted work capacity of 23.4%, which was significantly higher among participants who received AstraZeneca (33.6%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Participants had a good level of belief in vaccination safety and necessity. Healthcare workers who got the AstraZeneca vaccination reported more adverse effects than other vaccines. Injection site pain, fatigue, headache, muscle pains, and fever were the most frequently reported side effects. More research on vaccination safety is needed to understand the long-term adverse effects of vaccinations better, improve the public trust, and accelerate vaccine adoption.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s41182-022-00427-2","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T04:02:49Z","timestamp":1653883369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Perceptions and experiences of COVID-19 vaccines\u2019 side effects among healthcare workers at an Egyptian University Hospital: a cross-sectional study"],"prefix":"10.1186","volume":"50","author":[{"given":"Hisham Ahmed","family":"Orebi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham Elsayed","family":"Emara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah Ahmoud","family":"Alhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Reda","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arwa Hassan","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2555-1442","authenticated-orcid":false,"given":"Ibrahim Ali","family":"Kabbash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0189-1795","authenticated-orcid":false,"given":"Shimaa M.","family":"Saied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"issue":"4","key":"427_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/pcn.12988","volume":"74","author":"J Shigemura","year":"2020","unstructured":"Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the new coronavirus 2019 (2019-nCoV) in Japan: consequences for mental health and target populations. Psychiatry Clin Neurosci. 2020;74(4):281\u20132. https:\/\/doi.org\/10.1111\/pcn.12988.","journal-title":"Psychiatry Clin Neurosci"},{"key":"427_CR2","doi-asserted-by":"publisher","unstructured":"Zhonghua L, Xing B, Zhi Z. Novel coronavirus pneumonia emergency response epidemiology team. The epidemiological characteristics of an outbreak of. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. 2019. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2020.02.003.","DOI":"10.3760\/cma.j.issn.0254-6450.2020.02.003"},{"issue":"2","key":"427_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/L20-1134","volume":"173","author":"R Chou","year":"2020","unstructured":"Chou R, Dana T, Buckley DI, Selph S, Fu R, Totten AM. Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review. Ann Intern Med. 2020;173(2):120\u201336. https:\/\/doi.org\/10.7326\/L20-1134.","journal-title":"Ann Intern Med"},{"issue":"2","key":"427_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000519456","volume":"65","author":"AA Alghamdi","year":"2022","unstructured":"Alghamdi AA, Alkazemi A, Alissa A, Alghamdi I, Alwarafi G, Waggas HA. Adverse events following AstraZeneca COVID-19 vaccine in Saudi Arabia: a cross-sectional study among healthcare and nonhealthcare workers. Intervirology. 2022;65(2):104\u20139. https:\/\/doi.org\/10.1159\/000519456.","journal-title":"Intervirology"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijid.2021.01.013","volume":"104","author":"M Gholami","year":"2021","unstructured":"Gholami M, Fawad I, Shadan S, Rowaiee R, Ghanem H, Khamis AH, Ho SB. COVID-19 and healthcare workers: a systematic review and meta-analysis. Int J Infect Dis. 2021;104:335\u201346.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"427_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jiph.2021.09.011","volume":"14","author":"RH El-Sokkary","year":"2021","unstructured":"El-Sokkary RH, Daef E, El-Korashi LA, Khedr EM, Gad D, Mohamed-Hussein A, Zayed NE, Mostafa EF, Bahgat SM, Hassany SM, Amer MG. Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: a multicenter study from Egypt. J Infect Public Health. 2021;14(10):1474\u201380. https:\/\/doi.org\/10.1016\/j.jiph.2021.09.011.","journal-title":"J Infect Public Health"},{"key":"427_CR7","unstructured":"WHO Accelerating a safe and effective COVID-19 vaccine. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/accelerating-a-safe-and-effective-covid-19-vaccine. Accessed on March 7th 2022."},{"issue":"7","key":"427_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254456","volume":"16","author":"O Alagoz","year":"2021","unstructured":"Alagoz O, Sethi AK, Patterson BW, Churpek M, Alhanaee G, Scaria E, Safdar N. The impact of vaccination to control COVID-19 burden in the United States: a simulation modeling approach. PLoS ONE. 2021;16(7): e0254456. https:\/\/doi.org\/10.1371\/journal.pone.0254456.","journal-title":"PLoS ONE"},{"issue":"2","key":"427_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/jcm10020288","volume":"10","author":"S Attia","year":"2021","unstructured":"Attia S, Howaldt HP. Impact of COVID-19 on the dental community: part I before vaccine (BV). J Clin Med. 2021;10(2):288. https:\/\/doi.org\/10.3390\/jcm10020288.","journal-title":"J Clin Med"},{"issue":"34","key":"427_CR10","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1016\/j.vaccine.2015.04.040","volume":"33","author":"C Jarrett","year":"2015","unstructured":"Jarrett C, Wilson R, O\u2019Leary M, Eckersberger E, Larson HJ. Strategies for addressing vaccine hesitancy\u2013a systematic review. Vaccine. 2015;33(34):4180\u201390. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.040.","journal-title":"Vaccine"},{"issue":"45","key":"427_CR11","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1016\/j.vaccine.2017.09.046","volume":"35","author":"LE Smith","year":"2017","unstructured":"Smith LE, Aml\u00f4t R, Weinman J, Yiend J, Rubin GJ. A systematic review of factors affecting vaccine uptake in young children. Vaccine. 2017;35(45):6059\u201369. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.046.","journal-title":"Vaccine"},{"issue":"5","key":"427_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/vaccines9050446","volume":"9","author":"E Qunaibi","year":"2021","unstructured":"Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab healthcare workers towards COVID-19 vaccination: a large-scale multinational study. Vaccines. 2021;9(5):446. https:\/\/doi.org\/10.3390\/vaccines9050446.","journal-title":"Vaccines"},{"key":"427_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/d41586-020-01221-y","volume":"580","author":"E Callaway","year":"2020","unstructured":"Callaway E. Coronavirus vaccines. Nature. 2020;580:577. https:\/\/doi.org\/10.1038\/d41586-020-01221-y.","journal-title":"Nature"},{"key":"427_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6","author":"C Herve","year":"2019","unstructured":"Herve C, Laupeze B, Giudice GD, Didierlaurent AM, Silva F. The how\u2019s and what\u2019s of vaccine reactogenicity. NPJ Vaccines. 2019. https:\/\/doi.org\/10.1038\/s41541-019-0132-6.","journal-title":"NPJ Vaccines"},{"key":"427_CR15","unstructured":"World Health Organization Strategic Advisory Group of Experts on Immunization WHO SAGE Roadmap for Prioritizing uses of COVID-19 Vaccines in the Context of Limited Supply November 2020. Available online: https:\/\/www.who.int\/publications\/i\/item\/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines. Accessed on March 24th 2022."},{"issue":"15","key":"427_CR16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","volume":"385","author":"YM Bar-On","year":"2021","unstructured":"Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, Mizrahi B, Alroy-Preis S, Ash N, Milo R, Huppert A. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393\u2013400. https:\/\/doi.org\/10.1056\/NEJMoa2114255.","journal-title":"N Engl J Med"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"215013272110133","DOI":"10.1177\/21501327211013303","volume":"12","author":"S Fares","year":"2021","unstructured":"Fares S, Elmnyer MM, Mohamed SS, Elsayed R. COVID-19 vaccination perception and attitude among healthcare workers in Egypt. J Prim Care Community Health. 2021;12:21501327211013304. https:\/\/doi.org\/10.1177\/21501327211013303.","journal-title":"J Prim Care Community Health"},{"issue":"6","key":"427_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/vaccines9060556","volume":"9","author":"MM Hatmal","year":"2021","unstructured":"Hatmal MM, Al-Hatamleh MA, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 2021;9(6):556. https:\/\/doi.org\/10.3390\/vaccines9060556.","journal-title":"Vaccines"},{"issue":"5","key":"427_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273\u00a0SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med"},{"key":"427_CR20","unstructured":"Ministry of Health (MOH) Malaysia National COVID-19 Immunisation Programme the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (Jkjav) 2021; Ministry of Health (MOH): Kuala Lumpur, Malaysia, 2021."},{"issue":"1","key":"427_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06392-1","volume":"21","author":"RH El-Sokkary","year":"2021","unstructured":"El-Sokkary RH, El Seifi OS, Hassan HM, Mortada EM, Hashem MK, Gadelrab MR, Tash RM. Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study. BMC Infect Dis. 2021;21(1):1\u20139. https:\/\/doi.org\/10.1186\/s12879-021-06392-1.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"427_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/vaccines10010018","volume":"10","author":"MO Elgendy","year":"2021","unstructured":"Elgendy MO, El-Gendy AO, Alzarea AI, Mahmoud S, Alqahtani SS, Fahmy AM, El-Seedi HR, Sayed AM, Alatawi AD, Abdelrahim ME, Alanazi AS. SARS-CoV-2 post vaccinated adverse effects and efficacy in the Egyptian Population. Vaccines. 2021;10(1):18. https:\/\/doi.org\/10.3390\/vaccines10010018.","journal-title":"Vaccines"},{"key":"427_CR23","unstructured":"World Health Organization. Egypt. https:\/\/covid19.who.int\/region\/emro\/country\/eg. Accessed on May 5th 2022."},{"issue":"10","key":"427_CR24","doi-asserted-by":"publisher","first-page":"e0258236","DOI":"10.1371\/journal.pone.0258236","volume":"16","author":"MH Kim","year":"2021","unstructured":"Kim MH, Son NH, Park YS, Lee JH, Kim DA, Kim YC. Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects. PLoS ONE. 2021;16(10):e0258236. https:\/\/doi.org\/10.1371\/journal.pone.0258236.","journal-title":"PLoS ONE"},{"issue":"50","key":"427_CR25","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","volume":"69","author":"SE Oliver","year":"2020","unstructured":"Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR. The advisory committee on immunization practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 2020. MMWR. 2020;69(50):1922. https:\/\/doi.org\/10.15585\/mmwr.mm6950e2.","journal-title":"MMWR"},{"key":"427_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","volume":"106","author":"RA Kadali","year":"2021","unstructured":"Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. IJID. 2021;106:376\u201381. https:\/\/doi.org\/10.1016\/j.ijid.2021.04.047.","journal-title":"IJID"},{"issue":"2","key":"427_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ageing\/afaa274","volume":"50","author":"RL Soiza","year":"2021","unstructured":"Soiza RL, Scicluna C, Thomson EC. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing. 2021;50(2):279\u201383. https:\/\/doi.org\/10.1093\/ageing\/afaa274.","journal-title":"Age Ageing"},{"issue":"22","key":"427_CR28","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/jcm10225338","volume":"10","author":"A Dziedzic","year":"2021","unstructured":"Dziedzic A, Riad A, Attia S, Klugar M, Tanasiewicz M. Self-reported adverse events of COVID-19 vaccines in polish healthcare workers and medical students. Cross-sectional study and pooled analysis of CoVaST project results in central Europe. J Clin Med. 2021;10(22):5338. https:\/\/doi.org\/10.3390\/jcm10225338.","journal-title":"J Clin Med"},{"issue":"4","key":"427_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/vaccines9040393","volume":"9","author":"M Tobaiqy","year":"2021","unstructured":"Tobaiqy M, Elkout H, MacLure K. Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database. Vaccines. 2021;9(4):393. https:\/\/doi.org\/10.3390\/vaccines9040393.","journal-title":"Vaccines"},{"key":"427_CR30","unstructured":"WHO Official Website. Draft Landscape of COVID-19 Candidate Vaccines. Available online: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-COVID-19-candidate-vaccines (accessed on March 3rd 2021)."},{"key":"427_CR31","unstructured":"EMA Recommends COVID-19 Vaccine AstraZeneca for Authorisation in the EU. Available online: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu (accessed on March 3rd 2021)."},{"key":"427_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n699","volume":"372","author":"J Wise","year":"2021","unstructured":"Wise J. COVID-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021;372: n699. https:\/\/doi.org\/10.1136\/bmj.n699.","journal-title":"BMJ"},{"issue":"22","key":"427_CR33","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092\u2013101. https:\/\/doi.org\/10.1056\/NEJMoa2104840.","journal-title":"N Engl J Med"},{"key":"427_CR34","unstructured":"World Health Organization. Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm: grading of evidence: evidence to recommendation tables, first issued May 7th 2021, updated October 28th 2021 (No. WHO\/2019-nCoV\/vaccines\/SAGE_recommendation\/BIBP\/annexes\/2021.2). World Health Organization.\u200f 2021."},{"issue":"7","key":"427_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/14760584.2016.1184092","volume":"15","author":"J Raude","year":"2016","unstructured":"Raude J, Fressard L, Gautier A, Pulcini C, Peretti-Watel P, Verger P. Opening the \u201cVaccine Hesitancy\u201d black box: how trust in institutions affects French GPs\u2019 vaccination practices. Expert Rev Vaccines. 2016;15(7):937\u201348. https:\/\/doi.org\/10.1080\/14760584.2016.1184092.","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"427_CR36","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/vaccines9050502","volume":"9","author":"I J\u0119\u015bkowiak","year":"2021","unstructured":"J\u0119\u015bkowiak I, Wiatrak B, Grosman-Dziewiszek P, Szel\u0105g A. The incidence and severity of post-vaccination reactions after vaccination against COVID-19. Vaccines. 2021;9(5):502. https:\/\/doi.org\/10.3390\/vaccines9050502.","journal-title":"Vaccines"},{"issue":"6","key":"427_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s15010-021-01622-9","volume":"49","author":"S Bauernfeind","year":"2021","unstructured":"Bauernfeind S, Hitzenbichler F, Huppertz G, Zeman F, Koller M, Schmidt B, Plentz A, Bauswein M, Mohr A, Salzberger B. Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020. Infection. 2021;49(6):1307\u201311. https:\/\/doi.org\/10.1007\/s15010-021-01622-9.","journal-title":"Infection"},{"issue":"3","key":"427_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/vaccines9030218","volume":"9","author":"B Szmyd","year":"2021","unstructured":"Szmyd B, Karuga FF, Bartoszek A, Staniecka K, Siwecka N, Bartoszek A, B\u0142aszczyk M, Radek M. Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: a cross-sectional study from Poland. Vaccines. 2021;9(3):218. https:\/\/doi.org\/10.3390\/vaccines9030218.","journal-title":"Vaccines"},{"key":"427_CR39","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720005188","author":"D Freeman","year":"2020","unstructured":"Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, Innocenti S. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020. https:\/\/doi.org\/10.1017\/S0033291720005188.","journal-title":"Psychol Med"},{"issue":"5","key":"427_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/vaccines9050503","volume":"9","author":"M Babicki","year":"2021","unstructured":"Babicki M, Mastalerz-Migas A. Attitudes toward vaccination against COVID-19 in Poland. A longitudinal study performed before and two months after the commencement of the population vaccination programme in Poland. Vaccines. 2021;9(5):503. https:\/\/doi.org\/10.3390\/vaccines9050503.","journal-title":"Vaccines"},{"issue":"S2","key":"427_CR41","first-page":"100","volume":"26","author":"S Khadka","year":"2020","unstructured":"Khadka S, Yuchi A, Shrestha DB, Budhathoki P, Al-Subari SM, Alhouzani TZ, Butt AI. Repurposing drugs for COVID-19: an approach for treatment in the pandemic. Altern Ther Health Med. 2020;26(S2):100\u20137.","journal-title":"Altern Ther Health Med"},{"issue":"11","key":"427_CR42","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/vaccines9111369","volume":"9","author":"MN Zahid","year":"2021","unstructured":"Zahid MN. Unfolding the mild to moderate short-term side effects of four COVID-19 vaccines used in Bahrain: a cross-sectional study. Vaccines. 2021;9(11):1369. https:\/\/doi.org\/10.3390\/vaccines9111369.","journal-title":"Vaccines"},{"issue":"7","key":"427_CR43","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/jcm10071428","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1428. https:\/\/doi.org\/10.3390\/jcm10071428.","journal-title":"J Clin Med"},{"issue":"3","key":"427_CR44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/vaccines10030366","volume":"10","author":"MM Hatmal","year":"2022","unstructured":"Hatmal MM, Al-Hatamleh MA, Olaimat AN, Mohamud R, Fawaz M, Kateeb ET, Alkhairy OK, Tayyem R, Lounis M, Al-Raeei M, Dana RK. Reported adverse effects and attitudes among Arab populations following COVID-19 vaccination: a large-scale multinational study implementing machine learning tools in predicting post-vaccination adverse effects based on predisposing factors. Vaccines. 2022;10(3):366. https:\/\/doi.org\/10.3390\/vaccines10030366.","journal-title":"Vaccines"},{"key":"427_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","volume":"111","author":"BQ Saeed","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. IJID. 2021;111:219\u201326. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.013.","journal-title":"IJID"},{"key":"427_CR46","doi-asserted-by":"crossref","unstructured":"Serap BA, Burucu R, Cantekin I, D\u00f6nmez H. Determining the side effects of COVID-19 (Sinovac) vaccination on nurses; an independent descriptive study. Konuralp Med J. 13(S1):479\u201387.","DOI":"10.18521\/ktd.981790"},{"issue":"10","key":"427_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2020.15543","volume":"324","author":"S Xia","year":"2021","unstructured":"Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Yang X. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: Interim analysis of 2 randomized clinical trials. JAMA. 2021;324(10):951\u201360. https:\/\/doi.org\/10.1001\/jama.2020.15543.","journal-title":"JAMA"},{"issue":"5","key":"427_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102207","volume":"15","author":"HB Almufty","year":"2021","unstructured":"Almufty HB, Mohammed SA, Abdullah AM, Merza MA. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab Syndr Clin Res Rev. 2021;15(5): 102207. https:\/\/doi.org\/10.1016\/j.dsx.2021.102207.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"5","key":"427_CR49","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/vaccines9050522","volume":"9","author":"C Di Resta","year":"2021","unstructured":"Di Resta C, Ferrari D, Vigan\u00f2 M, Moro M, Sabetta E, Minerva M, Ambrosio A, Locatelli M, Tomaiuolo R. The gender impact assessment among healthcare workers in the SARS-CoV-2 vaccination\u2014an analysis of serological response and side effects. Vaccines. 2021;9(5):522. https:\/\/doi.org\/10.3390\/vaccines9050522.","journal-title":"Vaccines"},{"issue":"8","key":"427_CR50","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/biology10080752","volume":"10","author":"M Klugar","year":"2021","unstructured":"Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, Attia S. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology. 2021;10(8):752. https:\/\/doi.org\/10.3390\/biology10080752.","journal-title":"Biology"},{"key":"427_CR51","doi-asserted-by":"crossref","unstructured":"Mohsin M, Mahmud S, Mian AU, Hasan P, Muyeed A, Islam A, Rahman MM, Islam M, Khan HR, Rahman MS. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh. medRxiv. 2022.","DOI":"10.1101\/2022.01.31.22270172"},{"issue":"12","key":"427_CR52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s40264-021-01131-6","volume":"44","author":"N Luxi","year":"2021","unstructured":"Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C. COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre-and post-marketing evidence for vaccine efficacy and safety. Drug Saf. 2021;44(12):1247\u201369. https:\/\/doi.org\/10.1007\/s40264-021-01131-6.","journal-title":"Drug Saf"},{"key":"427_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108021","volume":"99","author":"M Negahdaripour","year":"2021","unstructured":"Negahdaripour M, Shafiekhani M, Moezzi SM, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol. 2021;99: 108021. https:\/\/doi.org\/10.1016\/j.intimp.2021.108021.","journal-title":"Int Immunopharmacol"}],"updated-by":[{"DOI":"10.1186\/s41182-022-00476-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000}}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-022-00427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-022-00427-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-022-00427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T02:07:37Z","timestamp":1727316457000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-022-00427-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s41182-022-00427-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s41182-022-00476-7","asserted-by":"object"}]},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s41182-022-00476-7","URL":"https:\/\/doi.org\/10.1186\/s41182-022-00476-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Committee of Scientific Research in the Tanta Faculty of Medicine approved the research before starting the study (No. 35033\/11\/21). For participants\u2019 consent, we inserted a written consent in the introductory page of the questionnaire, and all participants gave informed consent before answering the questions. Participation in this study was voluntary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}